BioStack Platforms
BioStack Platforms is a YC Spring 2026 (P26) company. Based in San Francisco, CA, USA.
About BioStack Platforms
Summary
BioStack Platforms builds a data engine for healthcare and drug discovery AI, serving AI labs and biotech startups that need high-quality, ML-ready training data. It sources and structures longitudinal, multimodal clinical and preclinical data, covering EHR, imaging, ECGs, lab results, notes, and patient outcomes, then packages it into post-training and reinforcement learning environments. The product replaces the slow, expensive process of assembling fragmented biomedical data from hospitals, labs, and CROs into usable form.
Business model
Fee-based engagements initiated through a consultation, with custom dataset and infrastructure delivery for each client.
Go-to-market
AI labs and biotech startups are the primary buyers, acquired through a consultation-led motion where prospects book a free session to scope their data needs.
From the Y Combinator listing
Real world training envs for healthcare AI models
BioStack is building the data engine for healthcare and drug discovery AI. The bottleneck is not models. It is access to high-quality biological data. Clinical and experimental data is fragmented, unstructured, and locked inside hospitals, labs, and CROs, while generating new data is slow and expensive. BioStack fixes this with proprietary clinical and preclinical data pipelines that turn real biomedical workflows into ML-ready training environments. We structure longitudinal multimodal data across imaging, EHR, and experimental assays, then package it for post-training and reinforcement learning so models can learn how research and care actually happen. Instead of static datasets, BioStack gives AI labs workflow-aligned data and environments that improve reasoning, decision-making, and real-world performance in biology and medicine.
Facts
- Healthcare / Healthcare
- San Francisco, CA, USA
- Active
- Early
Founders (2)
- Parth Patwa
Score every batch against your own thesis
GPAgent's sourcing agent reads every company in a batch, scores each one against your fund's thesis in a private workspace, and lines up the founders worth meeting before Demo Day. You decide who to contact. Your scores, notes, and pipeline never appear on these pages.
How Accelerator intelligence works